Document is current
Any future updates will be listed below
-
Authors
Godzenko, A. A.
Agafonova, E. M.
Dimitreva, A. E.
Razumova, I. Yu.
Urumova, M. M.
- License Information
-
More Information
Article History
Received: 3 April 2024
Revised: 8 April 2024
Accepted: 8 April 2024
First Online: 10 June 2024
CONFLICT OF INTEREST
: The authors of this work declare that they have no conflicts of interest.
: The study was carried out within the framework of scientific topic no. 1021051503111-9 “Improving the Diagnosis and Pharmacotherapy of Spondyloarthritis Based on Comparative Results of Studying Prognostic (Including Molecular Biological, Molecular Genetic, and Clinical Imaging) Factors of Disease Progression and the Level of Quality of Life of Patients,” approved by the Academic Council of the Nasonova Research Institute of Rheumatology. The study was approved by the Local Ethics Committee of the Nasonova Research Institute of Rheumatology (protocol no. 02 dated January 27, 2022). All study participants signed voluntary informed consent to participate in the study.
